RT Journal Article
SR Electronic
T1 Modeling hepatitis C virus kinetics during liver transplantation highlights the role of the liver in virus clearance
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.08.03.20167387
DO 10.1101/2020.08.03.20167387
A1 Shekhtman, Louis
A1 Navasa, Miquel
A1 Sansone, Natasha
A1 Crespo, Gonzalo
A1 Subramanya, Gitanjali
A1 Chung, Tje Lin
A1 Pérez-del-Pulgar, Sofía
A1 Perelson, Alan S.
A1 Cotler, Scott J.
A1 Uprichard, Susan L.
A1 Dahari, Harel
A1 Forns, Xavier
YR 2020
UL http://medrxiv.org/content/early/2020/08/04/2020.08.03.20167387.abstract
AB While the liver, specifically hepatocytes, are widely accepted as the main source for hepatitis C virus (HCV) production, the role of the liver/hepatocytes in the clearance of circulating HCV remains largely unknown. Here we evaluated the function of the liver/hepatocytes in clearing virus from the circulation by investigating viral clearance during liver transplantation and from culture medium in vitro. Frequent HCV kinetic data during liver transplantation were recorded from 5 individuals throughout the anhepatic (AH) phase and for 4 hours after reperfusion (RP), along with recordings of fluid balances. Using mathematical modeling, the serum viral clearance rate, c, was estimated. Analogously, we monitored the clearance rate of HCV at 37°C from culture medium in vitro in the absence and presence of chronically infected Huh7 human hepatoma cells. During the AH phase, in 3 transplant cases viral levels remained at pre-AH levels, while in the other 2 cases HCV declined (half-life, t1/2~1h). Immediately post-RP, virus declined in a biphasic manner in Cases 1-4 consisting of an extremely rapid (median t1/2=5min) decline followed by a slower decline (HCV t1/2=67min). In Case 5, HCV remained at the same level post-RP as at the end of AH. Declines in virus level were not explained by adjusting for dilution from IV fluid and blood products. Consistent with what was observed in the majority of patients in the anhepatic phase, the t1/2 of HCV in cell culture was much longer in the absence of chronically HCV-infected Huh7 cells. Therefore, kinetic and modeling results from both in vivo liver transplantation cases and in vitro cell culture studies suggest that the liver plays a major role in clearing HCV from the circulation.Competing Interest StatementXF acted as advisor for Gilead and AbbVie. None of the other authors has any financial interest or conflict of interest related to this researchFunding StatementThe study was supported, in part, by U.S. National Institute of Health grants: R01-AI078881 and R01-AI116868, Instituto de Salud Carlos III (PI15/00151 and PI13/00155) and by Secretaria dUniversitats i Recerca del Departament dEconomia i Coneixement (grant 2017_SGR_1753) and CERCA Programme/Generalitat de Catalunya, and Germany Academic Exchange Service.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Approved by IRB of Hospital Clinic BarcelonaAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesKinetic data will be available upon request.